Kirsten Tillisch1, Emeran A Mayer, Jennifer S Labus. 1. Center for Neurobiology of Stress, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, USA.
Abstract
BACKGROUND AND AIMS: The responsiveness of the central nervous system is altered in patients with irritable bowel syndrome (IBS). However, because of variations in experimental paradigms, analytic techniques, and reporting practices, little consensus exists on brain responses to visceral stimulation. We aimed to identify brain regions consistently activated by supraliminal rectal stimulation in IBS patients and healthy subjects (controls) by performing a quantitative meta-analysis of published studies. METHODS: Significant foci from within-group statistical parametric maps were extracted from published neuroimaging studies that employed rectal distension. Voxel-based activation likelihood estimation was applied, pooling the results and comparing them across groups. RESULTS: Across studies, there was consistent activation in regions associated with visceral afferent processing (ie, thalamus, insula, anterior midcingulate) among IBS patients and controls, but considerable differences in the extent and specific location of foci. IBS patients differed from controls in that there were more consistent activations in regions associated with emotional arousal (pregenual anterior cingulate cortex, amygdala) and activation of a midbrain cluster, a region playing a role in endogenous pain modulation. Controls showed more consistent activation of the medial and lateral prefrontal cortex. CONCLUSIONS: Patients with IBS have greater engagement of regions associated with emotional arousal and endogenous pain modulation, but similar activation of regions involved in processing of visceral afferent information. Controls have greater engagement of cognitive modulatory regions. These results support a role for central nervous system dysregulation in IBS. These findings provide specific targets for guiding development of future neuroimaging protocols to more clearly define altered brain-gut interactions in IBS.
BACKGROUND AND AIMS: The responsiveness of the central nervous system is altered in patients with irritable bowel syndrome (IBS). However, because of variations in experimental paradigms, analytic techniques, and reporting practices, little consensus exists on brain responses to visceral stimulation. We aimed to identify brain regions consistently activated by supraliminal rectal stimulation in IBSpatients and healthy subjects (controls) by performing a quantitative meta-analysis of published studies. METHODS: Significant foci from within-group statistical parametric maps were extracted from published neuroimaging studies that employed rectal distension. Voxel-based activation likelihood estimation was applied, pooling the results and comparing them across groups. RESULTS: Across studies, there was consistent activation in regions associated with visceral afferent processing (ie, thalamus, insula, anterior midcingulate) among IBSpatients and controls, but considerable differences in the extent and specific location of foci. IBSpatients differed from controls in that there were more consistent activations in regions associated with emotional arousal (pregenual anterior cingulate cortex, amygdala) and activation of a midbrain cluster, a region playing a role in endogenous pain modulation. Controls showed more consistent activation of the medial and lateral prefrontal cortex. CONCLUSIONS:Patients with IBS have greater engagement of regions associated with emotional arousal and endogenous pain modulation, but similar activation of regions involved in processing of visceral afferent information. Controls have greater engagement of cognitive modulatory regions. These results support a role for central nervous system dysregulation in IBS. These findings provide specific targets for guiding development of future neuroimaging protocols to more clearly define altered brain-gut interactions in IBS.
Authors: Angela R Laird; P Mickle Fox; Cathy J Price; David C Glahn; Angela M Uecker; Jack L Lancaster; Peter E Turkeltaub; Peter Kochunov; Peter T Fox Journal: Hum Brain Mapp Date: 2005-05 Impact factor: 5.038
Authors: Emeran A Mayer; Steven Berman; Brandall Suyenobu; Jennifer Labus; Mark A Mandelkern; Bruce D Naliboff; Lin Chang Journal: Pain Date: 2005-06 Impact factor: 6.961
Authors: Elena Constantinou; Katleen Bogaerts; Lukas Van Oudenhove; Jan Tack; Ilse Van Diest; Omer Van den Bergh Journal: Int J Behav Med Date: 2015-08
Authors: A Gupta; S Cole; J S Labus; S Joshi; T J Nguyen; L A Kilpatrick; K Tillisch; B D Naliboff; L Chang; E A Mayer Journal: Neurogastroenterol Motil Date: 2017-02-12 Impact factor: 3.598
Authors: A Vania Apkarian; Volker Neugebauer; George Koob; Scott Edwards; Jon D Levine; Luiz Ferrari; Mark Egli; Soundar Regunathan Journal: Pharmacol Biochem Behav Date: 2013-10-02 Impact factor: 3.533
Authors: Monica E Jarrett; Robert J Shulman; Kevin C Cain; Wimon Deechakawan; Lynne T Smith; Philippe Richebé; Margaret Eugenio; Margaret M Heitkemper Journal: Biol Res Nurs Date: 2014-01-24 Impact factor: 2.522
Authors: M B O Lowén; E A Mayer; M Sjöberg; K Tillisch; B Naliboff; J Labus; P Lundberg; M Ström; M Engström; S A Walter Journal: Aliment Pharmacol Ther Date: 2013-04-25 Impact factor: 8.171